Key facts
- Notable investors include Shicui Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Jingke Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Jingke Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jingke Pharmaceutical
Operator of a pharmaceutical company based in Huzhou, China.
- Sector
- Healthcare
- HQ
- Huzhou, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Jingke Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jingke Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jingke Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.